小胶质细胞
PI3K/AKT/mTOR通路
神经保护
神经炎症
蛋白激酶B
TLR4型
细胞生物学
促炎细胞因子
神经突
生物
信号转导
癌症研究
免疫学
炎症
药理学
生物化学
体外
作者
Jian Chen,Zhouguang Wang,Zengming Zheng,Yu Chen,Sinan Khor,Kesi Shi,Zili He,Qingqing Wang,Ying‐Zheng Zhao,Hongyu Zhang,Xiaokun Li,Jiawei Li,Jiayu Yin,Xiangyang Wang,Jian Xiao
标识
DOI:10.1038/cddis.2017.490
摘要
Therapeutics used to treat central nervous system (CNS) injury were designed to repair neurites and inhibit cell apoptosis. Previous studies have shown that neuron-derived FGF10 exerts potential neuroprotective effects after cerebral ischemia injury. However, little is known about the role of endogenous FGF10 in the recovery process after spinal cord injury (SCI). In this study, we found that FGF10 is mainly produced by neuron and microglia/macrophages, and its expression is increased after SCI. Exogenous treatment of FGF10 improved functional recovery after injury by reducing apoptosis, as well as repairing neurites via FGFR2/PI3K/Akt pathway. On another hand, inhibiting the PI3K/Akt pathway with LY294002 partially reversed the therapeutic effects of FGF10. In addition, small interfering RNA knockdown of FGFR2 suppressed PI3K/Akt pathway activation by FGF10 and abolished its anti-apoptotic and neurite repair effects in vitro. Furthermore, FGF10 treatment inhibited the activation and proliferation of microglia/macrophages through regulation of TLR4/NF-κB pathway, and attenuated the release of pro-inflammatory cytokines after SCI. Thus, the increased expression of FGF10 after acute SCI is an endogenous self-protective response, suggesting that FGF10 could be a potential treatment for CNS injury.
科研通智能强力驱动
Strongly Powered by AbleSci AI